
Stryker Corporation (SYK) – Active acquirer of technologies
in Company Report , Healthcare & Life Sciences , Medical Devices & Equipments on January 16, 2022Orthopaedics net sales increased 16.1% to $1.53bn in Q3FY21 as reported and 15.5% in constant currency, as foreign currency exchange rates positively impacted net sales by 0.6%. The unit volume decrease was due to lower shipments of hips, trauma and extremities and other orthopaedics products.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– DCF Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
Crispidea Coverage
No of Pages : 36